Title

Cancer treatment and monitoring methods using OX40 agonists

Inventors

Brendan Curti, Providence St. Joseph HealthFollow
Magdalena Kovacsovics-Bankowski
Ed Walker
Josh Walker
Andy Weinberg

Document Type

Patent

File Date

8-6-2014

Abstract

OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.

Clinical Institute

Cancer

Department

Oncology

Location

United States

Comments

Patent Number: 9,828,432

Assignee

PROVIDENCE HEALTH & SERVICES--OREGON (Renton, WA)

Family ID

48947845

Serial Number

14/376,998

Tech ID

12-07-INV

Recommended Citation

Curti, Brendan; Kovacsovics-Bankowski, Magdalena; Walker, Ed; Walker, Josh; and Weinberg, Andy, "Cancer treatment and monitoring methods using OX40 agonists" (2014). Technology Transfer - Patents. 33.
https://digitalcommons.providence.org/technologytransfer/33